Last updated on March 2019

A Study on the Control of Chronic Obstructive Pulmonary Disease (COPD) in Patients Taking the Combination of Tiotropium and Olodaterol Using the Respimat Inhaler


Brief description of study

Open-label observational study which includes COPD patients that are receiving treatment with Spiolto Respimat for approximately 6 weeks, which is the average time between two medical consultations.

Clinical Study Identifier: NCT03663569

Contact Investigators or Research Sites near you

Start Over

Boehringer Ingelheim

MUDr. Jan Faktor Medipont s.r.o.
Ceske Budejovice, Czechia
5.64miles
  Connect »

Boehringer Ingelheim

MUDr. Josef Hlavac Medipont s.r.o.
Ceske Budejovice, Czechia
5.64miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.